Key concerns now

1. Ferritin 3000 ng/mL + persistent fever + hepatomegaly
   • Consider secondary HLH/macrophage activation syndrome (MAS), especially with underlying rheumatoid disease, but ferritin alone is not diagnostic.
   • Also consider adult-onset Still disease, occult infection, lymphoma, severe inflammatory response, and less likely hepatic injury as isolated AST/ALT are normal.
   • HLH can initially look like sepsis. Look particularly for falling platelets, falling Hb/WBC, coagulopathy, high triglycerides, low fibrinogen, splenomegaly, and worsening LFTs. HLH-2004 requires 5 of 8 criteria, but in adults the HScore is useful as an early probability tool.
2. HCO3 12 with pH 7.40 and tachypnea
   • This is not reassuring. It means a significant metabolic acidosis is being offset by respiratory alkalosis or compensation.
   • Calculate anion gap immediately:
     AG = Na - (Cl + HCO3)
   • Use Winter's expected PCO2:
     Expected PCO2 = 1.5 × HCO3 + 8 ± 2 = 26 ± 2 mmHg.
   • If actual PCO2 is much lower than about 24, he has an additional respiratory alkalosis, seen in sepsis/inflammation, salicylate toxicity, liver disease, pulmonary processes, etc.
   • Normal lactate does not explain bicarbonate 12. Check ketones, glucose, renal trend, chloride, albumin-corrected AG, and consider salicylate level/toxicology if clinically plausible.
3. Fever with conjugated hyperbilirubinemia and normal AST/ALT
   • Think of inflammatory or sepsis-related cholestasis, hemolysis plus another process, biliary infection/obstruction, malaria, enteric fever, rickettsial illness, viral infection, or infiltrative disease.
   • Obtain ALP, GGT, PT/INR, albumin, LDH, haptoglobin, reticulocyte count, and peripheral smear.

Practical work-up today

1. Reassess severity and look for a focus

• Repeat full examination daily: skin and eschar search including groin/axilla/scalp, rash during fever spike, arthritis/synovitis, lymph nodes, hepatosplenomegaly, cardiac murmur/stigmata of endocarditis, fundus if symptoms, and careful abdominal exam.
• Repeat vitals, mental status, urine output, capillary glucose, and serial CBC/platelets.
• Given RR 34 and bicarbonate 12, consider monitored/HD unit care if tachypnea or acidosis persists or worsens.

2. Microbiology before any antibiotic escalation, if feasible

• Two to three sets of blood cultures from separate peripheral sites, ideally during a spike. Antibiotics may reduce yield, but cultures are still worthwhile.
• Urine routine/microscopy and culture.
• Sputum culture/AFB/NAAT only if respiratory symptoms or imaging findings emerge.
• HIV Ag/Ab.
• Hepatitis B surface antigen, hepatitis C antibody, and consider hepatitis A/E IgM according to local epidemiology and clinical setting.
• COVID/influenza testing if relevant locally.
• Peripheral smear for malaria plus rapid malaria antigen. If initial smear is negative but suspicion remains, repeat smears over 24-48 h.
• Scrub typhus IgM ELISA or PCR. Do not rely on absence of eschar.
• Blood culture for enteric fever if appropriate. Widal and Weil-Felix are not reliable rule-in or rule-out tests and should not drive treatment.
• Consider Q fever, brucellosis, and leptospirosis repeat/PCR based on exposures: livestock, raw dairy, abattoir work, rodents, floods, ticks, travel, and occupation.
• TB testing should be targeted to symptoms/imaging/epidemiology. In India or other high-burden settings, disseminated TB remains important.

3. Hyperferritinemia / HLH-MAS screen urgently

• CBC with differential and daily platelet trend
• Peripheral smear
• Fasting triglycerides
• Fibrinogen
• D-dimer, PT/INR, aPTT
• LDH, uric acid
• Repeat ferritin in 24-48 hours, looking at trajectory
• LFT including ALP/GGT, albumin
• Consider soluble IL-2 receptor/sCD25 and NK-cell activity if available, but do not delay specialist assessment awaiting them.
• EBV PCR, CMV PCR, and other trigger-directed testing if accessible.
• Calculate HScore once the above data are available.
• Hematology input early. Bone marrow aspiration/biopsy is reasonable if cytopenias appear, smear is abnormal, HLH probability is moderate-high, or there is concern for lymphoma/leukemia. Absence of hemophagocytosis does not exclude early HLH.

4. Imaging

• Repeat chest radiograph if the respiratory rate remains high. A normal early CXR does not rule out PE, early pneumonia, miliary TB, or inflammatory lung disease.
• CT chest, abdomen and pelvis with contrast if renal function permits, especially with persistent fever, hepatomegaly, high inflammatory markers, and no source. Look for occult abscess, lymphadenopathy, splenic lesions, malignancy, TB, or vascular pathology.
• Echocardiography, preferably TTE first, if any murmur, embolic features, persistent bacteremia, prosthetic material, IVDU, or no alternative source. Proceed to TEE if endocarditis remains plausible.
• If routine work-up is unrevealing, FDG-PET/CT can help locate occult inflammatory, infectious, or malignant foci. Recent evidence supports its diagnostic use in selected persistent fever cases, including suspected Still disease (systematic review, PMID 40838726).

5. Rheumatologic assessment

• Quotidian or double-quotidian high spiking fever
• Evanescent salmon-pink rash with fever
• Sore throat
• Neutrophilic leukocytosis
• Arthralgia/arthritis
• Lymphadenopathy or hepatosplenomegaly
• Marked ferritin elevation

Antimicrobial and steroid caution

• Reassess whether piperacillin-tazobactam plus doxycycline matches the leading infectious hypotheses and local resistance pattern. A fall in TLC does not prove the current regimen is treating the cause.
• Do not broaden antibiotics blindly without obtaining cultures and imaging unless he becomes unstable.
• Avoid empiric corticosteroids solely for ferritin 3000 until infection and hematologic malignancy have been actively assessed. However, if he develops worsening organ dysfunction and a multidisciplinary team considers HLH/MAS highly probable, hematology/rheumatology may recommend urgent immunomodulatory treatment while trigger investigations continue.
• In HLH, treating an infectious trigger alone may not be sufficient once immune activation is established. Goldman-Cecil Medicine, 2-volume set, p. 4495-4502.

Immediate red flags for escalation

• Hypotension, altered sensorium, oliguria, rising creatinine
• Increasing respiratory work, hypoxemia, rising anion gap, or falling pH
• Platelet/Hb/WBC decline
• INR rise, fibrinogen fall, DIC
• Ferritin rapidly rising, especially into very high levels
• Splenomegaly, worsening bilirubin/LFTs, or new lymphadenopathy

What the reports show

• Patient age on reports: 47 years, not 42.
• Persistent neutrophilic leukocytosis is improving: WBC 14.84 to 12.22 x10³/µL.
• Hb has fallen: 11.6 to 10.4 g/dL, normocytic. Platelets remain normal: 328 to 345 x10³/µL.
• Therefore, at present he has only one cytopenic lineage, anemia, not the 2-line cytopenia required as an HLH-2004 criterion.
• Ferritin reported: 3000 ng/mL.
• Hepatosplenomegaly and fever are present.
• Bilirubin is improving: 2.9/1.4 to 2.1/1.2 mg/dL. AST/ALT and ALP are essentially normal. This is mild mixed, predominantly indirect hyperbilirubinemia rather than clear obstructive cholestasis.
• CRP 50.2 mg/L, ESR 99 mm/h.
• Urine: 1+ protein, only 2-4 WBC/hpf, no RBC. This does not suggest UTI.
• Creatinine 0.7, urea 22: preserved renal function.
• HbA1c 7.14%, so diabetes is present, but random sugar 169 alone does not explain the bicarbonate of 12.

Important correction: this is high-anion-gap metabolic acidosis

• Repeat ABG/VBG with measured PCO2
• Repeat Na, K, Cl, bicarbonate, Mg, phosphate
• Serum beta-hydroxybutyrate and urine ketones
• Serum osmolarity and calculated osmolar gap
• Salicylate level, if any possibility of ingestion
• Repeat lactate
• Glucose trend

HLH/MAS: next tests today

• Fever
• Splenomegaly
• Ferritin >500

1. Fasting triglycerides
2. Fibrinogen
3. PT/INR, aPTT, D-dimer
4. LDH, uric acid, reticulocyte count, peripheral smear
5. Daily CBC with platelet count, LFT, ferritin
6. sCD25/soluble IL-2 receptor if available
7. EBV PCR, CMV PCR, HIV Ag/Ab
8. Hematology review and calculate HScore once triglyceride, fibrinogen, AST, cytopenia status, and marrow status are available.

Priority differential diagnosis in this case

1. Secondary HLH/MAS

2. Occult infection

• Repeat 2-3 blood culture sets, despite prior antibiotics.
• Malaria antigen and 3 peripheral smears over 24-48 h.
• Scrub typhus IgM ELISA/PCR and examine carefully for eschar.
• HIV, hepatitis B/C, EBV/CMV.
• Consider TB work-up, including CT imaging and targeted sampling.
• Exposure-directed tests: brucella, Q fever, visceral leishmaniasis if compatible travel/exposure history.
• Weil-Felix and Widal should not be used to exclude or confirm these diagnoses. The low Widal titres shown are negative/noncontributory.

3. Lymphoma or hematologic malignancy

• Contrast CT chest-abdomen-pelvis
• Careful node examination
• Peripheral smear reviewed by hematopathologist
• LDH and uric acid
• Bone marrow aspiration/biopsy if HScore is concerning, cytopenias progress, smear is abnormal, or CT shows nodes/splenic lesions.

4. Inflammatory disease

• Quotidian fever pattern
• Sore throat
• Evanescent rash during spikes
• Myalgia and arthritis/synovitis
• Serositis

Management position now

• This needs ID + hematology input today, and rheumatology if infection/malignancy studies remain unrevealing or HScore rises.
• Do not start steroids purely because ferritin is 3000. If fibrinogen is low, triglycerides high, counts fall, ferritin rises rapidly, or organ dysfunction develops, discuss urgent HLH/MAS-directed treatment with hematology while investigating triggers.
• Continue to reassess the antibiotic plan based on cultures, imaging, exposure history, and clinical deterioration, rather than broadening blindly.
• The USG report itself is not visible among the attached images, but accepting the stated hepatosplenomegaly, it makes the CT chest-abdomen-pelvis and HLH panel higher priority.